Atrial fibrillation (AF) is one of the most important risk factors for stroke, heart failure, and other cardiac disturbances, but little is known about the association with metabolic diseases such as diabetes mellitus (DM). Although several reports have studied their association, the results have been controversial and no large scale study has been reported in the real world clinical practice. We investigated the frequency of AF in 13,868 patients (DM: 6,202, AF: 309) who consulted our hospital in the last two years. We conducted a cross-sectional case-control study and examined the association between AF and metabolic diseases (DM, dyslipidemia) and cardiovascular and renal diseases (hypertension, heart failure, chronic renal failure). AF was observed in 3.26% of the DM group and 1.37% in the control group. The occurrence frequency between AF and DM was 2.40 as shown by the odds ratio of the risk of DM for AF (95% confidence interval; 1.89-3.06, p<0.01%). We demonstrated for the first time in a large scale investigation in the real world clinical practice that DM would significantly increase the risk of the onset of AF. It is recommended that patients with DM should take electrocardiography regularly and be intervened at an early stage.
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and is associated with an increased risk of cerebral infarction, heart failure, and overall mortality. Recently, AF has been attracting attention, due to its increased treatment options by release of novel oral anti-coagulants. Nevertheless, the important concept of the management of AF remains to be its prevention. Therefore, identification of risk factors is important, especially in the real world clinical practice.
In Japan, the number of patients with AF and the prevalence are on the increase, and are estimated to exceed one million by 2050 [
Recent meta-analysis has reported that diabetes can be a risk factor of AF [
The study design was based on the Japanese government’s Ethical Guidelines Regarding Epidemiological Studies in accordance with the Declaration of Helsinki. The protocol of the present study was approved by the institutional review board.
Subjects were selected from those who came to our hospital during the study period from May 2011 to April 2013. Diagnoses were made by attending physicians and were input into disease name database. Medical history was investigated based on the disease name database.
We conducted a cross-sectional case-control study for the analysis. Statistical analysis was conducted to calculate odds ratio. Here, we simply used Chi-square test for independence by two-by-two contingency table. The presence or absence of the history of treatment was not investigated.
Total 13,868 subjects were enrolled in this cross-sectional study during the study period.
AF | Total | |||
Yes | No | |||
DM | Yes | 209 | 6,202 | 6,411 |
No | 100 | 7,127 | 7,275 | |
Total | 309 | 13,329 | 13,868 |
Odd ratio=2.40 (1.89-3.06)
Chi-squared=54.012 (p<0.0001)
AF | Total | |||
Yes | No | |||
DL | Yes | 154 | 4,880 | 5,034 |
No | 155 | 8,679 | 8,834 | |
Total | 309 | 13,559 | 13,868 |
Odd ratio=1.77 (1.41-2.21)
Chi-squared=24.458 (p<0.0001)
AF | Total | |||
Yes | No | |||
HTN | Yes | 223 | 4,811 | 5,034 |
No | 86 | 8,748 | 8,834 | |
Total | 309 | 13,559 | 13,868 |
Odd ratio=4.71 (3.67-6.06)
Chi-squared=175.848 (p<0.0001)
AF | Total | |||
Yes | No | |||
CHF | Yes | 96 | 421 | 517 |
No | 213 | 13,138 | 8,834 | |
Total | 309 | 13,559 | 13,868 |
Odd ratio=14.06 (10.85-18.24)
Chi-squared=658.209 (p<0.0001)
AF | Total | ||||
Yes | No | ||||
CRF | Yes | 16 | 193 | 209 | |
No | 293 | 13,366 | 13,659 | ||
Total | 309 | 13,559 | 13,868 |
Odd ratio=3.78 (2.24-6.38)
Chi-squared = 28.692 (p<0.0001)
We first investigated the relationship between AF and metabolic diseases (DM, dyslipidemia). A significant relationship was seen between AF and diabetes. This means that diabetes is actually a risk factor of AF. The OR was 2.40 (95% confidence interval (CI); 1.89-3.06, p<0.0001) (
We then looked into the relationship between AF and cardiovascular diseases. We found that there was a significant relationship between AF and hypertension. The OR was 4.71 (95% CI; 3.67-6.06, p<0.0001) (
We finally analyzed chronic renal failure, and we found that it is a significant risk factor of AF. The OR of chronic renal failure was as high as 3.78 (95% CI; 2.24-6.38, p<0.0001) (
The results of risk factors contributing to the prevalence of AF are summarized in
Although several reports have reported an association between DM and AF, the results have been controversial and no large scale study has been reported in the real world clinical practice. To our knowledge, this is the first study which revealed the association in a large scale in the real world clinical practice.
Diabetes is important as one of the risk factors of the AF. Therefore, preventative treatment intervention is recommended, because the prognosis of asymptomatic patients with AF is poor. Early detection of the AF by periodical examination such as electrocardiography might be useful for the prevention of the onset of cerebral infarction for the patients with diabetes as well.
In general, onset frequency of the AF increases with the duration of DM. In many cases of DM, we found that paroxysmal AF tends to shifts to sustained AF, and finally to chronic AF. This is consistent with the experimental findings that atrial electromechanical function is impaired in diabetic rabbits, and is associated with atrial fibrosis and interatrial electrical conduction delay, promoting the onset of AF [
In conclusion, we demonstrated for the first time in a large scale investigation in Japan that DM would significantly increase the risk of the onset of AF. Therefore, it is recommended that patients with DM should take electrocardiography regularly and be intervened at an early stage in the real world clinical practice.